Global Blood Therapeutics

Array Biopharma, Global Blood Therapeutics to Work on Hematological Drug Discovery

The companies are partnering on various methods to treat blood diseases.

Array BioPharma Inc. and Global Blood Therapeutics today announced a multi-target drug discovery collaboration agreement to identify small molecule lead compounds targeting chronic blood-based diseases.  Array will develop assays and screen its proprietary lead generation library of 300,000 small molecules to identify both active site and allosteric modulators of certain Global Blood targets.  Array's library will allow for rapid hit confirmation and subsequent lead optimization.

Your rating: None Average: 5 (1 vote)
Syndicate content